Localized Controlled Release of Kynurenic Acid Encapsulated in Synthetic Polymer Reduces Implant—Induced Dermal Fibrosis

Excessive fibrosis following surgical procedures is a challenging condition with serious consequences and no effective preventive or therapeutic option. Our group has previously shown the anti-fibrotic effect of kynurenic acid (KynA) in vitro and as topical cream formulations or nanofiber dressings...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabai, Layla, Ghahary, Aziz, Jackson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331703/
https://www.ncbi.nlm.nih.gov/pubmed/35893802
http://dx.doi.org/10.3390/pharmaceutics14081546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331703/
https://www.ncbi.nlm.nih.gov/pubmed/35893802
http://dx.doi.org/10.3390/pharmaceutics14081546

Ejemplares similares